Thursday, December 25, 2025 | 05:38 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Concord Drugs Share Price

Know More
BSENSE

84.00 0.50 (0.60%)

04:01 PM, 24-Dec-2025
Stock not traded

BSE : 538965

Sector : Health care

ISIN Code : INE858L01010

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 24-Dec-2025 | 04:01 PM IST

Market Cap (₹ Cr)

84

Traded Value (₹ Cr)

0.04

Volume (Shares)

5,141

Face Value (₹)

10

52-Week High (₹)

92.52

52-Week High Date

13-Nov-2025

52-Week Low (₹)

26.10

52-Week Low Date

03-Mar-2025

All Time High (₹)

92.52

All Time High Date

13-Nov-2025

All Time Low (₹)

11.68

All Time Low Date

26-Mar-2020

Concord Drugs Ltd

Concord Drugs Limited established in 1995 is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals Dry Syrup powder) Tissue Bio-Adhesive tablets capsules and ophthalmic preparations and Ready-to-fill Pellets. The principal activity of the Company ...
Read More

Market News

More

Concord Drugs Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

84

EPS - TTM (₹) [C]

0.58

P/E Ratio (X) [C]

144.83

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [C]34.42
P/B Ratio (₹) [C]2.44

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Data Not Found

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

80.20

86.90

Week Low/High (₹)

78.65

88.00

Month Low/High (₹)

70.42

89.00

Year Low/High (₹)

26.10

93.00

All time Low/High (₹)

11.68

93.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week2.44%-1.00%1.25%
1 Month12.00%-0.60%0.70%
3 Month27.27%-4.52%4.33%
6 Month163.32%-4.09%4.38%
1 Year123.46%-8.84%10.18%
3 Year145.26%-42.72%46.81%

Company Info

Company Information

Chairman & Managing Director : S Nagi Reddy

Independent Director : K Ramchandra Reddy

Whole Time Director & Chief Financial Officer : Koni Reddy

Independent Director : S. Nagavenkata Hareesh

Whole-time Director : S. Manoj Kumar Reddy

Independent Director : Summela Kasu

Company Sec. & Compli. Officer : Namratha Nagla

Registered Office: Survey No 249 Brahmanapally V, Hayathnagar M,Ranga Reddy,Telangana-501511 Ph: 91-40-24036379

Email:concorddrugsltd@gmail.com

URL:http://www.concorddrugs.in

FAQs about Concord Drugs Ltd

1. What's the Concord Drugs Ltd share price today?
Concord Drugs Ltd share price was Rs 84.00 at 04:01 PM IST on 24th Dec 2025. Concord Drugs Ltd share price was up by 0.60% over the previous closing price of Rs 83.50. Concord Drugs Ltd share price trend:

  • Last 1 Month: Concord Drugs Ltd share price moved up by 12.00% on BSE.
  • Last 3 Months: Concord Drugs Ltd share price moved up by 27.27% on BSE.
  • Last 12 Months: Concord Drugs Ltd share price moved up by 123.46% on BSE.
  • Last 3 Years: Concord Drugs Ltd share price moved up by 145.26% on BSE.


2. How can I quickly analyse the performance of the Concord Drugs Ltd stock?
The performance of the Concord Drugs Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 144.83
  • Price to book value ratio is 2.44
  • The EPS (trailing 12 months) of the Concord Drugs Ltd stock is Rs 0.58


3. What is the market cap of Concord Drugs Ltd?
Concord Drugs Ltd has a market capitalisation of Rs 84 crore.


4. What is Concord Drugs Ltd's 52-week high/low share price?
The Concord Drugs Ltd’s 52-week high share price is Rs 92.52 and 52-week low share price is Rs 26.10.


5. Is the Concord Drugs Ltd profitable?
On a consolidated basis, Concord Drugs Ltd reported a profit of Rs 0.19 crore on a total income of Rs 10.28 crore for the quarter ended 2025.


6. Which are Concord Drugs Ltd’s peers in the Health care sector?
Concord Drugs Ltd’s top 5 peers in the Health care sector are Source Natural, Bharat Immunolog, Amwill Health, Concord Drugs, Vineet Laborator, Phaarmasia, Remedium Life.


7. Who owns how much in Concord Drugs Ltd?
Key changes to the Concord Drugs Ltd shareholding are as follows:

  • Promoter holding in Concord Drugs Ltd has gone up to 54.39 per cent as of Sep 2025 from 54.39 per cent as of Dec 2024.